Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bolak is a South Korean pharmaceutical and food additive company established in 1959. The company specializes in the manufacture of active pharmaceutical ingredients (APIs), food additives, and cosmetic raw materials. Its pharmaceutical portfolio includes products such as sucralfate for gastrointestinal treatments and various botanical extracts used in dermatological applications. Beyond healthcare, Bolak is a significant global supplier of food-grade saccharin and chewing gum bases. The company operates GMP-compliant manufacturing facilities and is publicly traded on the Korea Stock Exchange. Bolak's business model focuses on high-quality chemical synthesis and natural product extraction to serve diverse industrial sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bolak.